You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,629,968


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,629,968
Title: Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
Abstract:A reservoir-electrode for an iontophoretic delivery device of the present invention includes an electrode; and a hydrophilic reservoir situated in electrically conductive relation to the electrode. The reservoir is formed from a bibulous hydrophilic cross-linked polymeric material having a substantially uniform concentration of an alkali metal chloride salt therein thereby substantially eliminating concentration gradients of the salt with respect to the electrode. The polymeric material has a first surface and a second surface that is adhesively adherent to the electrode. The first surface of the polymeric material is releasably adhesive to an applied area of a patient's skin. The polymeric material has a cohesive strength, wherein a bond strength of an adhesive bond between the second surface of the polymeric material to the electrode is greater than the cohesive strength of the polymeric material and an adhesive bond strength of the first surface of the polymeric material to the applied area of the patient is less than the cohesive strength of the polymeric material so that upon removal of the reservoir-electrode from the applied area of the patient, substantially no polymeric material remains on the applied area and the reservoir remains substantially intact and adhesively adherent to the electrode.
Inventor(s): Jain; Uday K. (Mahway, NJ), Reddy; Vilambi N R K (Trichy TamiNadu, IN), Eliash; Bruce M. (Franklin Lakes, NJ), Carey; Kevin John (North Plainfield, NJ), Falevich; Vitaly (Ozone Park, NY), Keusch; Preston (Hazlet, NJ)
Assignee: Vyteris, Inc. (Fair Lawn, NJ)
Application Number:09/610,563
Patent Claim Types:
see list of patent claims
Formulation; Process; Delivery; Device; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,629,968: A Detailed Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 6,629,968, it is crucial to delve into the scope and claims to understand its significance, limitations, and position within the broader patent landscape. This analysis will help in identifying the patent's value, potential vulnerabilities, and its impact on related technologies.

Patent Overview

Patent Details

United States Patent 6,629,968, though not specifically detailed in the provided sources, would typically include information such as the title, inventors, assignees, filing and grant dates, and a detailed description of the invention.

Invention Description

The patent would describe the invention in detail, including its background, summary, and detailed description. This section is critical for understanding what the patent covers and how it differs from prior art.

Scope of Claims

Claim Structure

Patent claims are the most critical part of a patent application, as they define the scope of protection. Claims in a patent like 6,629,968 would be categorized into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims[5].

Claim Scope and Breadth

The scope of the claims must be carefully crafted to ensure they are not overly broad, which could lead to invalidation due to abstract idea exceptions or failure to meet the written description requirement. A balanced approach is necessary; broader claims may offer more protection but are harder to get allowed and more susceptible to challenges[5].

Patent Landscape Analysis

Family of Patents

If the patent is part of a family of patents, like those in the Cellect case, it would be important to analyze the relationships between these patents. This includes understanding which patents are continuations, continuations-in-part, or divisions, and how they claim priority from a common application[1].

Patent Term Adjustment (PTA)

For patents that have received PTA due to USPTO delays, the expiration dates can vary significantly. This adjustment can impact the overall patent landscape by extending the life of some patents beyond the standard 20-year term from the filing date of the priority application[1].

Obviousness-Type Double Patenting (ODP)

ODP Analysis

Patents within the same family can be subject to ODP analysis, which determines if claims in one patent are obvious variants of claims in another patent. This analysis is crucial to avoid invalidation of claims, as seen in the Cellect case where claims were invalidated due to ODP[1].

Patent-Eligible Subject Matter

Section 101 of the Patent Act

The patent must comply with Section 101 of the Patent Act, which defines patent-eligible subject matter. The claims must not be directed to ineligible concepts such as abstract ideas, natural phenomena, or laws of nature. If they are, they must contain an inventive concept that transforms the nature of the claim into a patent-eligible application[4].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

Using tools like a Claim Coverage Matrix, companies can analyze which patents and claims are actively protecting their intellectual property. This involves categorizing patents by claims and scope concepts to identify gaps or opportunities in the patent landscape[3].

Claim Charts

Interactive claim charts can help technical experts determine whether a particular scope concept is applicable to a target product or method. These charts are useful for identifying areas where claim coverage is lacking and highlighting future design opportunities[3].

Industry Impact and Stakeholder Views

Innovation and Investment

The patent's impact on innovation and investment in the relevant industry should be considered. Stakeholder views on patent subject matter eligibility can vary, with some groups supporting current exclusions and others advocating for changes to encourage more innovation, especially in emerging technologies like AI[4].

Key Takeaways

  • Claim Scope: The scope of claims must be balanced to avoid invalidation.
  • Patent Family: Understanding the relationships within a family of patents is crucial.
  • PTA: Patent Term Adjustments can extend the life of patents.
  • ODP: Obviousness-Type Double Patenting analysis is essential for patent validity.
  • Patent-Eligible Subject Matter: Compliance with Section 101 of the Patent Act is necessary.
  • Patent Analytics: Tools like Claim Coverage Matrices and claim charts are vital for analyzing patent coverage.

FAQs

Q: What is the importance of claim scope in a patent application?

A: The claim scope is critical as it defines the protection offered by the patent. Overly broad claims can be difficult to get allowed and are more susceptible to invalidation.

Q: How does Patent Term Adjustment (PTA) affect patent expiration dates?

A: PTA can extend the life of a patent beyond the standard 20-year term from the filing date of the priority application due to delays in the USPTO's processing.

Q: What is Obviousness-Type Double Patenting (ODP), and why is it important?

A: ODP is an analysis to determine if claims in one patent are obvious variants of claims in another patent. It is crucial to avoid invalidation of claims within a family of patents.

Q: How does Section 101 of the Patent Act impact patent eligibility?

A: Section 101 defines patent-eligible subject matter, excluding abstract ideas, natural phenomena, and laws of nature. Claims must comply with this section to be patent-eligible.

Q: What role do patent analytics tools play in managing a patent portfolio?

A: Patent analytics tools, such as Claim Coverage Matrices and claim charts, help in identifying gaps in patent coverage, highlighting future design opportunities, and ensuring that the patent portfolio is efficiently managed.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.
  4. Patent-Eligible Subject Matter Reform: An Overview - CRS Reports
  5. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law Group

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,629,968

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.